hypofractionated radiation

hypofractionated radiation

doses of radiation given less frequently than daily.

hy·po·frac·tion·at·ed ra·di·a·tion

(hī'pō-frak'shŭn-ā-tĕd rā'dē-ā'shŭn)
Larger fractions of a dose of radiation given less frequently than daily.
References in periodicals archive ?
Randomized Trial of a Hypofractionated Radiation Regimen for the Treatment of Localized Prostate Cancer.
Today, Cleveland Clinic and other centers are using hypofractionated radiation regimens, which significantly reduce the number of treatments.
However, hypofractionated radiation therapy control rate was gradually reported surpassing the traditional fraction significantly.
Long-term results of hypofractionated radiation therapy for breast cancer.
2% of the permitted cohort received hypofractionated radiation therapy in 2013.
The reason for this discrepancy was the introduction of a hypofractionated radiation protocol, which was introduced with the aim of reducing waiting times by using higher, but fewer, daily doses of radiation, and thereby decreasing the overall duration of treatment.
31] Hypofractionated radiation therapy offers the advantage of a more efficient and productive use of radiotherapy departments resources; whether machine time, staffing of treatment units, lower expenses in addition to far better patients convenience.
Typically, patients can finish treatment in 4 weeks or less with hypofractionated radiation therapy.
2% for women in the hypofractionated radiation group, with approximately 70% of patients having good to excellent cosmetic results.
In a multivariate Cox analysis, hypofractionated radiation therapy reduced the risk of biochemical failure by roughly 70% (hazard ratio 0.
The InTempo System takes the treatment of prostate cancer to an entirely new level, giving clinicians added confidence when delivering high-dose, hypofractionated radiation.
associate professor of radiation oncology, University of Wisconsin School of Medicine and Public Health, on a clinical trial to investigate use of the HioArt system for new approaches to hypofractionated radiation therapy for prostate cancer;